drugset / Trial / NCT01677338
Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This study is a multi-center, open-label comparison study and aimed to evaluate the preliminary performance of this 13C-uracil GEBT to examine its abilities of identifying abnormal (delayed) gastric emptying rates in subjects.
Timeline
- Start
- 2013-07
- Primary completion
- 2014-06
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 13C-uracil | Unknown | 100 mg | Oral |
| Subject | 99mTc sulfur colloid | Diagnostic / imaging agent | 500 unknown | Oral |